T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
The Greenbrier Companies
GBX
$1.43B
| $1.21M | ﹤0.01% |
25,900
| – | – |
|
|
EGN
1677
DELISTED
Energen
EGN
| $1.21M | ﹤0.01% |
17,740
+169
| +1% | +$11.8K |
|
|
UBP
1678
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $1.21M | ﹤0.01% |
70,536
+42,845
| +155% | +$746K |
|
1679
Element Solutions
ESI
$9.5B
| $1.2M | ﹤0.01% |
46,900
+9,700
| +26% | +$262K |
|
1680
Citizens Financial Group
CFG
$31.2B
| $1.2M | ﹤0.01% |
43,900
+24,600
| +127% | +$652K |
|
|
CST
1681
DELISTED
CST Brands, Inc.
CST
| $1.2M | ﹤0.01% |
30,611
+4,500
| +17% | +$187K |
|
|
AMSG
1682
DELISTED
Amsurg Corp
AMSG
| $1.2M | ﹤0.01% |
17,100
| – | – |
|
1683
Curtiss-Wright
CW
$25.3B
| $1.2M | ﹤0.01% |
16,500
| – | – |
|
1684
Huntsman Corp
HUN
$1.82B
| $1.19M | ﹤0.01% |
54,000
| – | – |
|
|
OA
1685
DELISTED
Orbital ATK, Inc.
OA
| $1.19M | ﹤0.01% |
16,164
| – | – |
|
|
TECD
1686
DELISTED
Tech Data Corp
TECD
| $1.19M | ﹤0.01% |
20,580
| – | – |
|
1687
Manulife Financial
MFC
$72.8B
| $1.18M | ﹤0.01% |
63,700
+1,500
| +2% | +$27.9K |
|
|
BMS
1688
DELISTED
Bemis
BMS
| $1.18M | ﹤0.01% |
26,300
+4,700
| +22% | +$215K |
|
1689
Sarepta Therapeutics
SRPT
$1.94B
| $1.18M | ﹤0.01% |
38,748
+12,200
| +46% | +$249K |
|
|
ITC
1690
DELISTED
ITC HOLDINGS CORP
ITC
| $1.18M | ﹤0.01% |
36,633
+46
| +0.1% | +$1.6K |
|
1691
Bank of Montreal
BMO
$129B
| $1.17M | ﹤0.01% |
19,800
-377
| -2% | -$23.7K |
|
|
INFN
1692
DELISTED
Infinera Corporation Common Stock
INFN
| $1.17M | ﹤0.01% |
55,700
+14,900
| +37% | +$303K |
|
|
UIL
1693
DELISTED
UIL HOLDINGS
UIL
| $1.17M | ﹤0.01% |
25,499
| – | – |
|
|
DEL
1694
DELISTED
Deltic Timber
DEL
| $1.16M | ﹤0.01% |
17,200
-870,908
| -98% | -$57.2M |
|
1695
Allison Transmission
ALSN
$10.1B
| $1.15M | ﹤0.01% |
39,300
+3,300
| +9% | +$103K |
|
|
WCC
1696
WESCO International
WCC
$17.7B
| $1.15M | ﹤0.01% |
16,751
| – | – |
|
1697
ITT
ITT
$19.3B
| $1.15M | ﹤0.01% |
27,400
| – | – |
|
|
CVG
1698
DELISTED
Convergys
CVG
| $1.15M | ﹤0.01% |
44,900
+10,900
| +32% | +$264K |
|
|
CVA
1699
DELISTED
Covanta Holding Corporation
CVA
| $1.14M | ﹤0.01% |
54,004
+6,500
| +14% | +$142K |
|
1700
Ryman Hospitality Properties
RHP
$7.88B
| $1.14M | ﹤0.01% |
21,489
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.